Currat Matthieu Pascal

Historique de performance de Currat Matthieu Pascal

Historique insuffisant pour un historique de performance statistique (moins de 5 achats sur le marché).

Historique des transactions de Currat Matthieu Pascal

Co-initiés de Currat Matthieu Pascal

• Aggarwal SumitEloxx Pharmaceuticals, Inc.
• Androski LindsayEloxx Pharmaceuticals, Inc.
• Avnur ZafriraEloxx Pharmaceuticals, Inc.
• BASKETT FORESTEloxx Pharmaceuticals, Inc.
• Baum Bryan DanielEloxx Pharmaceuticals, Inc.
• BAYER AKTIENGESELLSCHAFTEloxx Pharmaceuticals, Inc.
• BAYER HEALTHCARE LLCEloxx Pharmaceuticals, Inc.
• Bayer US Holding LPEloxx Pharmaceuticals, Inc.
• Bayer World Investments B.V.Eloxx Pharmaceuticals, Inc.
• Beck GillonEloxx Pharmaceuticals, Inc.
• Belloff Neil S.Eloxx Pharmaceuticals, Inc.
• Berland Susan DEloxx Pharmaceuticals, Inc.
• BERMAN JACOBEloxx Pharmaceuticals, Inc.
• BRACA JOHN NEloxx Pharmaceuticals, Inc.
• BROOKS JOELEloxx Pharmaceuticals, Inc.
• Browne Leslie JEloxx Pharmaceuticals, Inc.
• Celadon Partners SPV 24Eloxx Pharmaceuticals, Inc.
• Coastlands Capital LPEloxx Pharmaceuticals, Inc.
• Collins James J.Eloxx Pharmaceuticals, Inc.
• COOPERSTONE BRENDAEloxx Pharmaceuticals, Inc.
• Cross John Harry IIIEloxx Pharmaceuticals, Inc.
• Domicilium Real Estate Fund III LPEloxx Pharmaceuticals, Inc.
• Dondero Richard SEloxx Pharmaceuticals, Inc.
• Dynamics Sponsor LLCEloxx Pharmaceuticals, Inc.
• Epstein David REloxx Pharmaceuticals, Inc.
• Farokhzad OmidEloxx Pharmaceuticals, Inc.
• FEDYSZYN SASCHA PEloxx Pharmaceuticals, Inc.
• Florence Anthony A. Jr.Eloxx Pharmaceuticals, Inc.
• FORBES CHRISTOPHEREloxx Pharmaceuticals, Inc.
• Frost Gamma Investment TrustEloxx Pharmaceuticals, Inc.
• FROST PHILLIP MD ET ALEloxx Pharmaceuticals, Inc.
• GALTON BRUCE CEloxx Pharmaceuticals, Inc.
• GEFFKEN DANIEL EEloxx Pharmaceuticals, Inc.
• GRAZIANO JAMES JOSEPHEloxx Pharmaceuticals, Inc.
• Haubert Fabien WilliamEloxx Pharmaceuticals, Inc.
• Heft RobertEloxx Pharmaceuticals, Inc.
• Herberts Curt A. IIIEloxx Pharmaceuticals, Inc.
• Hsiung FengEloxx Pharmaceuticals, Inc.